An observational study in Coronary Artery Disease, sponsored by Scripps Translational Science Institute. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-01-16.
Sponsored by Scripps Translational Science Institute · Observational
This research is being done to understand how changes in DNA may put people at risk for developing coronary artery disease. Stem cells will be made using cells from blood and/or skin biopsy samples. We are trying to understand which specific changes in DNA negatively impact a person's health.
Subjects previously enrolled in the Scripps Genebank or Healthy Elderly Active Longevity (HEAL) Cohort
Cases:
Controls:
Exclusion Criteria:
Subjects previously enrolled in the Scripps Genebank Study
Subjects previously enrolled in the Scripps Healthy Elderly Active Longevity (HEAL) Cohort
iPSC development
Develop methods of iPSC generation from patients with genomic risk.
Time frame: five years
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Scripps Translational Science Institute